NHC vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

NHC

58.5
AI Score
VS
NHC Wins

PACS

30.9
AI Score

Investment Advisor Scores

NHC

59score
Recommendation
HOLD

PACS

31score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NHC PACS Winner
Forward P/E 9.8912 17.2414 NHC
PEG Ratio 0.8241 1.1488 NHC
Revenue Growth 8.8% 9.1% PACS
Earnings Growth 67.1% 51.6% NHC
Tradestie Score 58.5/100 30.9/100 NHC
Profit Margin 9.0% 4.9% NHC
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY NHC

Relative Price Performance (Last 90 Days)

NHC 1M: -9.1% · 3M: -4.3% PACS 1M: +12.8% · 3M: +11.3%

Current Technical Phase

NHC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.6%), weak momentum, RSI 43

RSI (14): 42.9 · Price: $210.38

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 60

RSI (14): 60.5 · Price: $50.06

Fundamentals Snapshot

Metric NHC PACS
Market Cap — —
Forward P/E 9.9 17.6
Trailing P/E 28.8 27.7
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.4% 0.2%
Operating Margin 0.1% 0.1%
EPS 7.23 1.77
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, NHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.